drugset / Trial / NCT07432581

Topical Insulin Dressing on Management of Diabetic Foot Ulcers

NCT07432581

Completed 30 enrolled Cairo University
RandomizedParallel-groupOpen-labelTreatment

Summary

This study aimed to find out the advantages of topical insulin in the management of diabetic foot ulcers over the conventional wound saline dressing.

Timeline

Start
2023-01-01
Primary completion
2024-01-01
Completion
2024-01-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Insulin Protein / enzyme biologic 4 iu Topical

Indications